Abbott Laboratories vs. Ironwood Pharmaceuticals, Inc. - Class A
ABT
Abbott Laboratories
$110.36 -1.88%
VS IRWDIronwood Pharmaceuticals, Inc. - Class A
$4.25 +2.91%
Abbott Laboratories (ABT) comes out ahead, leading on 5 of 9 compared factors.
Size & Scale
| ABT | IRWD | |
|---|---|---|
| Market Cap | $194.62 billion | $682.44 million |
| Revenue (TTM) | $46.59 billion | $389.32 million |
| Net Income (TTM) | $5.42 billion | $129.87 million |
ABT leads on 3 of 3 size & scale factors.
Valuation
| ABT | IRWD | |
|---|---|---|
| P/E Ratio | 35.72 | 5.52 |
| Price / Book | 3.76 | -4.22 |
| Price / Sales | 4.18 | 1.75 |
IRWD leads on 3 of 3 valuation factors.
Profitability
| ABT | IRWD | |
|---|---|---|
| Net Margin | 11.65% | 33.36% |
| Return on Equity | 10.48% | -80.24% |
ABT and IRWD split the profitability factors evenly.
Dividend
| ABT | IRWD | |
|---|---|---|
| Dividend Yield | 2.28% | — |
| Payout Ratio | 81.55 | — |
ABT and IRWD split the dividend factors evenly.
Risk & Sentiment
| ABT | IRWD | |
|---|---|---|
| Short Interest | 0.57% | 11.02% |
ABT leads on 1 of 1 risk & sentiment factors.
Dig deeper: ABT overview, ABT financials, IRWD overview, IRWD financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.